Does all this translate into reducing cravings, eating less, and losing weight
In the IMPROVE-IT trial, it proved effective and clean, just the occasional mild GI or liver effect, nothing unexpected
The pattern is well-documented in the orthostatic headache literature
At first, the dose is 0.25 mg
This qualitative tracking reveals whether you're undereating (persistent fatigue, irritability, cold intolerance) or finding sustainable balance
Ongoing support, regular follow-ups, and realistic expectations are key to achieving the best possible outcomes